This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Nuvo Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 1/6
Key information
1,149.7%
Debt to equity ratio
CA$97.55m
Debt
| Interest coverage ratio | 1.3x |
| Cash | CA$31.26m |
| Equity | CA$8.49m |
| Total liabilities | CA$118.77m |
| Total assets | CA$127.26m |
Recent financial health updates
Nuvo Pharmaceuticals (TSE:MRV) Has A Somewhat Strained Balance Sheet
Aug 17
Is Nuvo Pharmaceuticals (TSE:MRV) Using Too Much Debt?
Sep 01These 4 Measures Indicate That Nuvo Pharmaceuticals (TSE:MRV) Is Using Debt Extensively
Feb 22Recent updates
Nuvo Pharmaceuticals (TSE:MRV) Has A Somewhat Strained Balance Sheet
Aug 17Is Nuvo Pharmaceuticals (TSE:MRV) Using Too Much Debt?
Sep 01Nuvo Pharmaceuticals Inc.'s (TSE:MRV) CEO Might Not Expect Shareholders To Be So Generous This Year
May 11These 4 Measures Indicate That Nuvo Pharmaceuticals (TSE:MRV) Is Using Debt Extensively
Feb 22Financial Position Analysis
Short Term Liabilities: MRV's short term assets (CA$51.8M) exceed its short term liabilities (CA$24.6M).
Long Term Liabilities: MRV's short term assets (CA$51.8M) do not cover its long term liabilities (CA$94.2M).
Debt to Equity History and Analysis
Debt Level: MRV's net debt to equity ratio (781.3%) is considered high.
Reducing Debt: MRV's debt to equity ratio has increased from 0% to 1149.7% over the past 5 years.
Debt Coverage: MRV's debt is not well covered by operating cash flow (15.9%).
Interest Coverage: MRV's interest payments on its debt are not well covered by EBIT (1.3x coverage).